TUMOUR MARKER DECREASED

This adverse event was reported 179 times

These drugs are most commonly taken by patients reporting TUMOUR MARKER DECREASED:

# Drug Count
0 RIBOCICLIB 45
1 LETROZOLE 29
2 LETROZOLE TABLETS 24
3 ALPELISIB 23
4 PALBOCICLIB 23
5 FULVESTRANT 22
6 DENOSUMAB 15
7 EXEMESTANE 15
8 ZOLEDRONIC ACID 14
9 EVEROLIMUS 12
See all common drugs associated with TUMOUR MARKER DECREASED

TUMOUR MARKER DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 RIBOCICLIB 45 0.0014
1 ELACESTRANT 6 0.0008
2 EXEMESTANE 15 0.0007
3 ESTROGEN 2 0.0007
4 FULVESTRANT 22 0.0007
5 LETROZOLE TABLETS 24 0.0005
6 LETROZOLE 29 0.0005
7 IVOSIDENIB 1 0.0005
8 FAM-TRASTUZUMAB DERUXTECAN-NXKI 5 0.0005
9 NIRAPARIB 10 0.0005
See all drugs enriched for association with TUMOUR MARKER DECREASED